NICE recommends new treatment option for adults with obesity and non-diabetic hyperglycaemia who have a high risk of cardiovascular disease

Author: 
Dr Dipesh Patel
Date of the announcement: 
Monday, 2 November, 2020

NICE approve Saxenda injections (GLP-1 therapy) for people with pre-diabetes who have BMI of at least 35 kg/m2 and high cardiovascular risk. Further details outlined on NICE website:

https://www.nice.org.uk/news/article/nice-recommends-new-treatment-option-for-adults-with-obesity-and-non-diabetic-hyperglycaemia-who-have-a-high-risk-of-cardiovascular-disease

Information for HCPs

COVID-19 Information for Healthcare Professionals

ABCD Webinar Series

ABCD Webinars